Pettegrew J W, Kopp S J, Minshew N J, Glonek T, Feliksik J M, Tow J P, Cohen M M
J Neuropathol Exp Neurol. 1987 Jul;46(4):419-30. doi: 10.1097/00005072-198707000-00002.
31P nuclear magnetic resonance (NMR) studies were conducted on perchloric acid extracts of the brain of one control, two Huntington's disease (HD), one probable Alzheimer's disease (AD), and one AD patient. These studies demonstrated significant elevations (over control) in the levels of phosphomonoesters in all brain areas of the patients with HD and AD even in areas devoid of neuropathological findings. Elevations of phosphodiesters were also observed, but they tended to reflect the degree of neuropathological change. We postulate that the 31P NMR findings represent molecular alterations with corresponding metabolic correlates which either antedate or occur in the absence of changes in cellular morphology or structure. As such the 31P NMR findings may reflect a subcellular "molecular neuropathology."
对一名对照者、两名亨廷顿舞蹈症(HD)患者、一名疑似阿尔茨海默病(AD)患者以及一名AD患者的脑高氯酸提取物进行了31P核磁共振(NMR)研究。这些研究表明,HD和AD患者所有脑区的磷酸单酯水平(相对于对照者)显著升高,即使在没有神经病理学发现的区域也是如此。还观察到磷酸二酯升高,但它们往往反映神经病理学变化的程度。我们推测,31P NMR结果代表了分子改变及其相应的代谢关联,这些改变要么先于细胞形态或结构变化出现,要么在细胞形态或结构无变化的情况下发生。因此,31P NMR结果可能反映了亚细胞层面的“分子神经病理学”。